Blocking inflammation: a new arsenal against atherosclerosis
Endocrinol Diabetes Nutr. 2017 Dec;64(10):515-516.
doi: 10.1016/j.endinu.2017.10.003.
Epub 2017 Nov 13.
[Article in
English,
Spanish]
Affiliations
- 1 Departamento de Medicina Preventiva y Salud Pública, Universidad de Navarra - IdiSNA, Pamplona, España; CIBER Fisiopatología de la Obesidad y Nutrición (CIBER Obn), Instituto de Salud Carlos III, Madrid, España.
- 2 Departamento de Medicina Preventiva y Salud Pública, Universidad de Navarra - IdiSNA, Pamplona, España; CIBER Fisiopatología de la Obesidad y Nutrición (CIBER Obn), Instituto de Salud Carlos III, Madrid, España; Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Estados Unidos. Electronic address: mamartinez@unav.es.
No abstract available
MeSH terms
-
Antibodies, Monoclonal / immunology
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Atherosclerosis / etiology
-
Atherosclerosis / physiopathology
-
Atherosclerosis / prevention & control*
-
C-Reactive Protein / analysis
-
Clinical Trials as Topic
-
Diet, Mediterranean
-
Follow-Up Studies
-
Humans
-
Inflammation / complications
-
Inflammation / diet therapy
-
Inflammation / drug therapy*
-
Inflammation / physiopathology
-
Interleukin-1beta / antagonists & inhibitors*
-
International Cooperation
-
Life Style
-
Multicenter Studies as Topic
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Interleukin-1beta
-
canakinumab
-
C-Reactive Protein